NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. QCOM
6. ACN
7. AZN
8. ROIV
9. AAPL
10. HOOD

Go back to NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x
(NASDAQ: NTHI) Delayed: 4.07 -0.96 (19.09%)
Previous Close $5.03    52 Week High $ 
Open $4.99    52 Week Low $ 
Day High $5.02    P/E N/A 
Day Low $3.92    EPS $ 
Volume 417,488